|
|
Volumn 11, Issue 8, 2012, Pages 585-586
|
|
Overtaking the DILI model-T
a
a
NONE
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
5 FLUORO 3 PHENYL 2 [1 (9H PURIN 6 YLAMINO)PROPYL] 3H QUINAZOLIN 4 ONE;
PANADIPLON;
TROGLITAZONE;
CLINICAL EFFECTIVENESS;
CONVALESCENCE;
DISEASE ASSOCIATION;
DRUG APPROVAL;
DRUG EFFECT;
DRUG EFFICACY;
DRUG INDUSTRY;
DRUG MONITORING;
DRUG SAFETY;
GENE EXPRESSION REGULATION;
GENETIC ANALYSIS;
HUMAN;
HYPERTRANSAMINASEMIA;
IDIOPATHIC DISEASE;
INTERDISCIPLINARY RESEARCH;
LIVER CELL CULTURE;
LIVER INJURY;
LIVER TOXICITY;
MALIGNANT NEOPLASTIC DISEASE;
NONHUMAN;
OUTCOME ASSESSMENT;
PEROXISOME;
PRIORITY JOURNAL;
PUBLIC-PRIVATE PARTNERSHIP;
RISK ASSESSMENT;
SHORT SURVEY;
TOXIC HEPATITIS;
UPREGULATION;
ANIMALS;
CLINICAL TRIALS AS TOPIC;
COOPERATIVE BEHAVIOR;
DRUG DESIGN;
DRUG INDUSTRY;
DRUG-INDUCED LIVER INJURY;
HUMANS;
MODELS, BIOLOGICAL;
PHARMACEUTICAL PREPARATIONS;
TOXICITY TESTS;
|
|
EID: 84864558821
PISSN: 14741776
EISSN: 14741784
Source Type: Journal
DOI: 10.1038/nrd3818 Document Type: Short Survey |
|
Times cited : (9)
|
|
References (0)
|
